PLEASE HELP ME! THANK YOU! Prepare a Vertical Analysis for the two companies. Comment on the strengths and weaknesses of the company and the overall financial health

Column1	Johnson N Johnson	Pfizer
Fiscal year is January-December. All values USD Millions.	2019	2019
Sales/Revenue	82,113	41,172
Sales Growth	0.71%	-23.25%
Cost of Goods Sold (COGS) incl. D&A	27,135	12,623
COGS excluding D&A	20,126	6,828
Depreciation & Amortization Expense	7,009	5,795
Depreciation	2,509	1,333
Amortization of Intangibles	4,500	4,462
COGS Growth	-0.19%	-21.15%
Gross Income	54,978	28,549
Gross Income Growth	1.16%	-24.15%
Gross Profit Margin	-	-
SG&A Expense	33,428	21,038
Research & Development	11,250	8,364
Other SG&A	22,178	12,674
SGA Growth	1.01%	-5.87%
EBIT	21,550	-
Unusual Expense	6,008	4,079
Non Operating Income/Expense	2,198	9,384
Non-Operating Interest Income	357	225
Interest Expense	769	1,573
Interest Expense Growth	-35.59%	19.53%
Gross Interest Expense	839	1,661
Interest Capitalized	70	88
Pretax Income	17,328	11,485
Pretax Income Growth	-3.73%	-3.37%
Pretax Margin	-	-
Income Tax	2,209	618
Income Tax - Current Domestic	1,941	-2,208
Income Tax - Current Foreign	2,744	2,418
Income Tax - Deferred Domestic	-814	1,271
Income Tax - Deferred Foreign	-1,662	-863
Consolidated Net Income	15,119	10,867
Net Income	15,119	10,838
Net Income Growth	-1.16%	-2.74%
Net Margin	-	-
Net Income After Extraordinaries	15,119	5,403
Net Income Available to Common	15,119	16,272